FIC Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$3.51M Sell
18,505
-320
-2% -$60.9K 1.34% 22
2017
Q2
$3.54M Sell
18,825
-87
-0.5% -$15.6K 1.46% 20
2017
Q1
$3.13M Sell
18,912
-105
-0.6% -$16.7K 1.39% 25
2016
Q4
$2.73M Buy
19,017
+4,568
+32% +$612K 1.38% 27
2016
Q3
$1.81M Sell
14,449
-36
-0.2% -$4.65K 0.81% 40
2016
Q2
$1.9M Buy
14,485
+5,465
+61% +$748K 0.9% 37
2016
Q1
$1.25M Sell
9,020
-120
-1% -$16K 0.61% 49
2015
Q4
$1.27M Buy
+9,140
New +$1.26M 0.56% 52

Other funds holding ELV

FIC Capital's ELV Position: Q3 2017 in Review

FIC Capital reduced its Elevance Health (ELV) stake by 1.7% in Q3 2017, selling an estimated $60.9K and leaving 18,505 shares worth $3.51M. The position accounts for 1.34% of the portfolio, ranked #22.

FIC Capital first reported a position in ELV in Q4 2015 and has held it in 8 quarters since. The position peaked at $3.54M in Q2 2017. 844 funds tracked by Wall St. Rank hold ELV as of Q3 2017.

  • FIC Capital held 18,505 shares of Elevance Health worth $3.51M as of Q3 2017.
  • FIC Capital sold 320 Elevance Health shares in Q3 2017, an estimated $60.9K.
  • Elevance Health made up 1.34% of FIC Capital's portfolio in Q3 2017, its #22 holding.
  • FIC Capital first reported a position in Elevance Health in Q4 2015 and has held it in 8 quarters since.
  • FIC Capital's Elevance Health position peaked at $3.54M in Q2 2017.
  • 844 funds tracked by Wall St. Rank held Elevance Health as of Q3 2017.

Based on FIC Capital's 13F filing for Q3 2017, filed 14 Nov 2017.